– Berlin Heals Holding AG welcomes Dr. Felix Baader and Roland Diggelmann as new members of the management board
– The final phase of the ongoing CE study begins
ZUG, Switzerland, Aug. 22, 2023 /PRNewswire/ — Berlin Heals Holding AG (Berlin Heals), a Swiss medical technology company, is pleased to announce the appointments of Dr. Felix Baader and Roland Diggelmann as new members of the board of directors . Since 2014, the company has developed a completely new and innovative method for the treatment of heart failure and, following a successful first human study, is currently moving forward with a CE study for approval of its proprietary technology.
“We are very excited to welcome Dr. Baader and Diggelmann, two medical technology experts with vast experience and strategic vision, to the Berlin Heals board of directors,” said Dr. Ulf Berg, Chairman of the Board of Directors. “The timing couldn’t be better. Our goal is to obtain CE certification soon. We hope that the ongoing CE certification study will confirm the excellent results of the pilot study; the results of the corresponding study should be available around the end of 2024. Being able to incorporate two new high-profile board members to the company now is an important step for us.”
Dr Felix Baader commented: “Dr Felix Baader commented: ‘I am honored to be part of the Berlin Heals board of directors at this important stage. The company has a revolutionary product that will massively and sustainably improve the quality of life for many heart patients.” Dr. Baader has held several key positions in the healthcare and technology sectors over the past 30 years, including at Roche Diagnostics, Biotronik and Philips, and currently holds terms on the board of directors of Congenius, Valtronic Holding and Bibus Group AG, among other companies.”
“Berlin Heals’ C-MIC device is a game changer for dilated cardiomyopathy therapy and has significant market potential, not only reducing the length of hospital stay, but also easing the burden on health insurers. health and hospitals”, explained Roland Diggelmann. As a former CEO of Roche Diagnostics and the British medical technology company, Smith
Berlin Heals Holding AG is a public limited company founded in 2014 by the well-known cardiologist and doctor, Johannes Müller, and the businessman Marko Bagaric. The company has developed a new therapy, “C-MIC” (cardiac microcurrent), which uses constant microcurrent to rapidly and sustainably improve inflammatory parameters in the heart of heart failure patients. Currently, patient enrollment in the ongoing CE trial is approximately 60%. To date, more than 35 C-MIC devices have been successfully implanted and continue to show promising results.
Media contact: Marko Bagaricinfo@berlinheals. com
Logo : https://mma.prnewswire.com/media/1843666…
View original content: https://www.prnewswire.com/news-releases/berlin-heals-holding-ag-da-la-bienvenida-al-doctor-felix-baader-y-roland-diggelmann-301905441.html
